హోమ్ » అన్నీ » స్టాక్ సూచన » Vertex Pharmaceuticals Incorporated Common Stock సూచన

Vertex Pharmaceuticals Incorporated Common Stock సూచన: రేపు, వారం, నెల, 5 సంవత్సరాలు

నవీకరించబడింది: April 22 · 2026 at 07:03 UTC

From

▼ -0.59%Market Cap $111.09B · Technical analysis Bearish · Focus area Price + volatility

సూచన సారాంశం

కాలపరిమితి	అంచనా ధర	గతం	చారిత్రాత్మకమైనది	అంతర్దృష్టి
రేపు	$433.50 ▼ -0.71%	నిన్న	$437.89 ▲ +0.30%	Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $436.59 and targets $433.50 (-0.71%). The near-term read is downside; watch $449.69 / $423.49 because daily realized volatility is about 3.65%.
Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $436.59 and targets $433.50 (-0.71%). The near-term read is downside; watch $449.69 / $423.49 because daily realized volatility is about 3.65%.
వారం	$426.99 ▼ -2.20%	గత వారం	$440.62 ▲ +0.92%	The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $440.62 to $426.99 (-2.20%). It gives downside momentum context for this stock, so breaks around $449.69 / $423.49 matter more than a single tick.
The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $440.62 to $426.99 (-2.20%). It gives downside momentum context for this stock, so breaks around $449.69 / $423.49 matter more than a single tick.
నెల	$416.13 ▼ -4.69%	గత నెల	$445.18 ▲ +1.97%	The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-4.69%), compared with the live reference near $436.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-4.69%), compared with the live reference near $436.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
సంవత్సరం	$399.87 ▼ -8.41%	గత సంవత్సరం	$452.01 ▲ +3.53%	The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $399.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $399.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 సంవత్సరాలు	$361.75 ▼ -17.14%	5 సంవత్సరాల క్రితం	$468.02 ▲ +7.20%	The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $361.75 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $361.75 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

రేపు$433.50▼ -0.71%

నిన్న$437.89▲ +0.30%

Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $436.59 and targets $433.50 (-0.71%). The near-term read is downside; watch $449.69 / $423.49 because daily realized volatility is about 3.65%.

వారం$426.99▼ -2.20%

గత వారం$440.62▲ +0.92%

The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $440.62 to $426.99 (-2.20%). It gives downside momentum context for this stock, so breaks around $449.69 / $423.49 matter more than a single tick.

నెల$416.13▼ -4.69%

గత నెల$445.18▲ +1.97%

The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-4.69%), compared with the live reference near $436.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

సంవత్సరం$399.87▼ -8.41%

గత సంవత్సరం$452.01▲ +3.53%

The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $399.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 సంవత్సరాలు$361.75▼ -17.14%

5 సంవత్సరాల క్రితం$468.02▲ +7.20%

The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $361.75 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

ధర చార్ట్

చారిత్రాత్మకమైనదిసూచనబుల్లిష్బేరిష్

సాంకేతిక విశ్లేషణ

Bearish

బుల్లిష్

తటస్థ

బేరిష్

కీ సూచికలు

సూచిక	విలువ	సిగ్నల్
Price	$436.59	Mid
Daily Change	-0.59%	Below
Volatility Cap	20.0%	Mid
Confidence	58%	Below
Data Source	nasdaq-screener	Mid

హిస్టారికల్ డేటా

Current$436.59

Daily Change-0.59%

Market Cap$111.09B

Sourcenasdaq-screener

Current	$436.59	Daily Change	-0.59%
Market Cap	$111.09B	Source	nasdaq-screener

మద్దతు & ప్రతిఘటన స్థాయిలు

$423.49Support 1

$436.59ప్రస్తుత

$449.69Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

ధర మైలురాళ్ళు

కీలక స్థాయిలు & చారిత్రక సందర్భం

Current$436.59Live reference price

Used as the anchor for generated forecast calculations.

Next Month$416.13Model projection-4.69%

Directional scenario based on capped drift.

సూచన ఖచ్చితత్వం

మా మోడల్ ఎలా పనిచేసింది

58%

దిశాత్మక

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

తాజా ధర చర్య, అస్థిరత పాలన మరియు సూచిక సంకేతాలను ఉపయోగించి మా అల్గారిథమ్ ప్రతి వారం తిరిగి క్రమాంకనం చేయబడుతుంది. కాలపరిమితిని బట్టి ఖచ్చితత్వం మారుతుంది - దీర్ఘకాలిక అంచనాల కంటే స్వల్పకాలిక మొమెంటం మరింత నమ్మదగినది.

Short term

58%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

పెట్టుబడి దృశ్యాలు

మీరు ఈరోజు VRTXలో $1,000ని ఇన్వెస్ట్ చేస్తే

Bullish Scenario

$458.42

+5.00% from current

లక్ష్య ధర$458.42

దృశ్యంUpside momentum

సంభావ్యత50%

Base Scenario

$416.13

-4.69%

లక్ష్య ధర$416.13

దృశ్యంCapped drift

సంభావ్యత58%

Bearish Scenario

$414.76

-5.00% from current

లక్ష్య ధర$414.76

దృశ్యంVolatility drawdown

సంభావ్యత42%

ఆధారం: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

సూచన కారకాలు

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 40/100

24H drift-0.71%

7D drift-2.20%

30D drift-4.69%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 35/100

1M outlook-4.69%

1Y outlook-8.41%

5Y outlook-17.14%

తరచుగా అడిగే ప్రశ్నలు

Q What is the Vertex Pharmaceuticals Incorporated Common Stock (VRTX) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Vertex Pharmaceuticals Incorporated Common Stock is projected near $433.50 versus the current reference around $436.59. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for VRTX?

The weekly Vertex Pharmaceuticals Incorporated Common Stock model points to $426.99, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Vertex Pharmaceuticals Incorporated Common Stock 1-month and 1-year targets?

The Vertex Pharmaceuticals Incorporated Common Stock 1-month target is $416.13 (-4.69%), while the 1-year target is $399.87 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Vertex Pharmaceuticals Incorporated Common Stock 5-year scenario differ from short-term rows?

The Vertex Pharmaceuticals Incorporated Common Stock long-horizon scenario sits near $361.75 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are VRTX support and resistance zones right now?

For Vertex Pharmaceuticals Incorporated Common Stock, nearest resistance is around $423.49, while nearest support is around $449.69. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Vertex Pharmaceuticals Incorporated Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.